Fragment-based lead discovery: a chemical update

被引:116
作者
Erlanson, Daniel A. [1 ]
机构
[1] Sunesis Pharmaceut Inc, San Francisco, CA 94080 USA
关键词
D O I
10.1016/j.copbio.2006.10.007
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Fragment-based lead discovery constructs drug leads from small molecular fragments. In theory, this is a highly efficient method for drug discovery, and the technique has become enormously popular in the past few years. In this review, I describe how a variety of approaches in fragment-based lead discovery - including NMR, X-ray crystallography, mass spectrometry, functional screening, and in silico screening have produced drug leads. Although the examples show that the technique can reliably generate potent molecules, there is still much work to be done to maintain the efficiency of molecules' binding affinities as fragments are linked, expanded, and otherwise improved.
引用
收藏
页码:643 / 652
页数:10
相关论文
共 84 条
  • [61] An inhibitor of Bcl-2 family proteins induces regression of solid tumours
    Oltersdorf, T
    Elmore, SW
    Shoemaker, AR
    Armstrong, RC
    Augeri, DJ
    Belli, BA
    Bruncko, M
    Deckwerth, TL
    Dinges, J
    Hajduk, PJ
    Joseph, MK
    Kitada, S
    Korsmeyer, SJ
    Kunzer, AR
    Letai, A
    Li, C
    Mitten, MJ
    Nettesheim, DG
    Ng, S
    Nimmer, PM
    O'Connor, JM
    Oleksijew, A
    Petros, AM
    Reed, JC
    Shen, W
    Tahir, SK
    Thompson, CB
    Tomaselli, KJ
    Wang, BL
    Wendt, MD
    Zhang, HC
    Fesik, SW
    Rosenberg, SH
    [J]. NATURE, 2005, 435 (7042) : 677 - 681
  • [62] Oslob J. D., 2004, DRUG DISCOV TODAY-TA, V3, P143
  • [63] NMR-based techniques in the hit identification and optimisation processes
    Pellecchia, M
    Becattini, B
    Crowell, KJ
    Fattorusso, R
    Forino, M
    Fragai, M
    Jung, D
    Mustelin, T
    Tautz, L
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2004, 8 (06) : 597 - 611
  • [64] Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis
    Petros, AM
    Dinges, J
    Augeri, DJ
    Baumeister, SA
    Betebenner, DA
    Bures, MG
    Elmore, SW
    Hajduk, PJ
    Joseph, MK
    Landis, SK
    Nettesheim, DG
    Rosenberg, SH
    Shen, W
    Thomas, S
    Wang, XL
    Zanze, I
    Zhang, HC
    Fesik, SW
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (02) : 656 - 663
  • [65] Discovery of novel low molecular weight inhibitors of IMPDH via virtual needle screening
    Pickett, SD
    Sherborne, BS
    Wilkinson, T
    Bennett, J
    Borkakoti, N
    Broadhurst, M
    Hurst, D
    Kilford, I
    McKinnell, M
    Jones, PS
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (10) : 1691 - 1694
  • [66] Estradiol-adenosine hybrid compounds designed to inhibit type 1 17-β-hydroxysteroid dehydrogenase
    Poirier, D
    Boivin, RP
    Tremblay, MR
    Bérubé, M
    Qiu, W
    Lin, SX
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (26) : 8134 - 8147
  • [67] Fragment-based lead discovery
    Rees, DC
    Congreve, M
    Murray, CW
    Carr, R
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (08) : 660 - 672
  • [68] In silico fragment-based discovery of DPP-IV S1 pocket binders
    Rummey, C
    Nordhoff, S
    Thiemann, M
    Metz, G
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (05) : 1405 - 1409
  • [69] Discovery of potent inhibitors of dihydroneopterin aldolase using crystaLEAD high-throughput X-ray crystallographic screening and structure-directed lead optimization
    Sanders, WJ
    Nienaber, VL
    Lerner, CG
    McCall, JO
    Merrick, SM
    Swanson, SJ
    Harlan, JE
    Stoll, VS
    Stamper, GF
    Betz, SF
    Condroski, KR
    Meadows, RP
    Severin, JM
    Walter, KA
    Magdalinos, P
    Jakob, CG
    Wagner, R
    Beutel, BA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (07) : 1709 - 1718
  • [70] Library design for fragment based screening
    Schuffenhauer, A
    Ruedisser, S
    Marzinzik, AL
    Jahnke, W
    Blommers, M
    Selzer, P
    Jacoby, E
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (08) : 751 - 762